Home
Subscribe (free)
About NaturalNews
Contact Us
Write for NaturalNews
Media Info
Advertising Info
Health fraud

New England Journal of Medicine Admits to Publishing Potentially Fraudulent Lung Cancer Study

Wednesday, August 20, 2008 by: David Gutierrez, staff writer
Tags: health fraud, health news, Natural News


Most Viewed Articles
https://www.naturalnews.com/023920_cancer_lung_medicine.html
Delicious
diaspora
Print
Email
Share

(NaturalNews) In a correction and editorial, the New England Journal of Medicine (NEJM) has revealed that a study on a new method of diagnosing lung cancer might have been tainted by financial conflicts of interest.

"We and our readers were surprised to learn that the source of the funding of the charitable foundation was, in fact, a large corporation that could have an interest in the study results,'' the editorial read in part. "It is important to ask whether a study on clinical outcomes in lung cancer should be directly underwritten in part by the tobacco industry.''

The study in question concluded that lung cancer deaths could be reduced 80 percent by the use of computed tomopgraphic (CT) scans to detect the cancer earlier. From the beginning, the study attracted controversy, with critics charging that early diagnosis did not prove a decreased death rate, and that the method delivers many false positives that could lead to unnecessary biopsies.

Then in March, the New York Times revealed that the study had in fact been almost entirely funded by a tobacco company.

In the correction, study author Claudia Henschke clarified that $3.6 million, or "virtually all" of the study funding from the Foundation for Lung Cancer had been contributed by Vector Group Ltd., parent company of Liggett Tobacco.

Vector had announced its funding of Henschke's research as early as 2000, but this was not disclosed to the NEJM.

The journal was aware, however, that Henschke and co-author David Yankelevitz were receiving royalties from General Electric, a major manufacturer of CT machines, for their pending patents on ways to manipulate and interpret data from the scans. This conflict of interest was not disclosed when the article was published.

The NEJM announced that it would be implementing stricter requirements for study authors to disclose their funding sources.

"It had not been a practice at the time to ask people about the pedigree of their sources," chief editor Jeffrey Drazen said. "This has been a learning process for us."

Sources for this story include: www.bloomberg.com, online.wsj.com.

Receive Our Free Email Newsletter

Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.


comments powered by Disqus


Natural News Wire (Sponsored Content)

Science.News
Science News & Studies
Medicine.News
Medicine News and Information
Food.News
Food News & Studies
Health.News
Health News & Studies
Herbs.News
Herbs News & Information
Pollution.News
Pollution News & Studies
Cancer.News
Cancer News & Studies
Climate.News
Climate News & Studies
Survival.News
Survival News & Information
Gear.News
Gear News & Information
Glitch.News
News covering technology, stocks, hackers, and more